Evidence map›Paper›PMID 40599576›Full record

ArticleRSC advances2025

Tonatzin Zertuche-Arias, Manuel Alatorre-Meda, Ignacio A Rivero, Patricia Juárez, Ana B Castro-Ceseña

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tonatzin Zertuche-AriasDepartamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California (CICESE) Carretera Ensenada-Tijuana No. 3918, Zona Playitas, C.P. 22860 Ensenada Baja California Mexico pjuarez@cicese.mx acastro@cicese.mx.
Manuel Alatorre-MedaSECIHTI-Tecnológico Nacional de México, Instituto Tecnológico de Tijuana, Centro de Graduados e Investigación en Química-Grupo de Biomateriales y Nanomedicina Blvd. Alberto Limón Padilla S/N, C.P. 22510 Tijuana Baja California Mexico.
Ignacio A RiveroTecnológico Nacional de México, Centro de Graduados e Investigación en Química Tijuana 22510 BC Mexico.
Patricia JuárezDepartamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California (CICESE) Carretera Ensenada-Tijuana No. 3918, Zona Playitas, C.P. 22860 Ensenada Baja California Mexico pjuarez@cicese.mx acastro@cicese.mx.
Ana B Castro-CeseñaDepartamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California (CICESE) Carretera Ensenada-Tijuana No. 3918, Zona Playitas, C.P. 22860 Ensenada Baja California Mexico pjuarez@cicese.mx acastro@cicese.mx.ORCID https://orcid.org/0000-0001-8121-7874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone regeneration requires coordination between bone formation, vascularization, and inflammatory regulation. However, current biomaterials often fail to provide mechanical stability and sustained bioactivity while supporting cell viability. This study presents the development and characterization of hydrogels composed of methacrylated gelatin (GelMA) and chitosan methacrylate (ChMA), crosslinked by photopolymerization (GC hydrogels). These were evaluated for their mineralization potential

Identifiers

PMID40599576
PMCPMC12212046

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.